RavenQuest Lists Warrants
(firmenpresse) -
RAVENQUEST LISTS WARRANTS
NR18-21-June 29, 2018
June 29, 2018 - Vancouver, British Columbia - RavenQuest BioMed Inc. (CSE: RQB OTCQB:RVVQF Frankfurt: 1IT) (RavenQuest) is pleased to announce that warrants issued pursuant to its February 28, 2018 brokered private placement (the Warrants) have been approved for listing by the Canadian Securities Exchange (the CSE). Each Warrant is exercisable for a two-year period from the date of issuance at a price of $1.50 per common share, subject to acceleration in the event that the closing price of the Companys common shares on the CSE is greater than $2.75 for a period of ten consecutive trading days. The Warrants will commence trading on the CSE at the open of markets on July 3, 2018 under the ticker symbol RQB.WT.
About RavenQuest BioMed Inc.
RavenQuest is a diversified publicly traded cannabis company with divisions focused upon cannabis production, management services & consulting and specialized research & development. RavenQuest is a licensed producer with facilities located in Markham, Ontario and Edmonton, Alberta. RavenQuest maintains a research partnership with Montreal's McGill University focused upon cultivar (strain) recognition, plant stabilization and yield maximization of the cannabis plant.
The Company focuses on partnerships with Indigenous communities and has announced an MOU to construct a cannabis production facility on sovereign land of Fort McMurray First Nation #468. RavenQuest has also recently announced an LOI to acquire Western Agripharma Ltd., a late stage application with a production facility under construction on British Columbia's sunshine coast, a short ferry ride from Vancouver, BC.
On Behalf of the Board of Directors of
RAVENQUEST BIOMED INC.
"George Robinson"
Chief Executive Officer
For further information, please contact:- -
Mathieu McDonald, Corporate Communications 604-484-1230
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.
RavenQuest BioMed Inc. (formerly Ravencrest Resources Ltd.)
Suite 2300 - 1177 West Hastings Street, Vancouver, BC, V6E 2K3
T: 604-484-1230 / F: 604-409-7499
Leseranfragen:
" alt="TriStar Gold: More Positive Drilling Results from Tristar Gold´s Castelo De Sonhos">
" alt="Medigene AG: Medigene presents at upcoming conferences">
Datum: 02.07.2018 - 08:08 Uhr
Sprache: Deutsch
News-ID 577665
Anzahl Zeichen: 2552
contact information:
Town:
Wien
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 236 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"RavenQuest Lists Warrants
"
steht unter der journalistisch-redaktionellen Verantwortung von
RavenQuest Biomed Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
